Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTOR^TM2 trial to a real-world study: a head-to-head comparison

J Thromb Thrombolysis. 2023 Jan;55(1):195. doi: 10.1007/s11239-022-02744-z. Epub 2022 Dec 1.

Samantha Pasca^{1

2}, PierGiorgio Cojutti^{3

4}, Federico Pea^{3

4}, Ezio Zanon⁵; Italian rFXIII Study Group

¹ Department of Biomedical Sciences (DSB), Padua University Hospital, Padua, Italy. sampasca27@gmail.com.
² Department of Medicine (DIMED), Padua University Hospital, Padua, Italy. sampasca27@gmail.com.
³ SSD Clinical Pharmacology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
⁴ Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
⁵ General Medicine, Hemophilia Center, Padua University Hospital, Padua, Italy.

No abstract available